1. Home
  2. KALV vs CABO Comparison

KALV vs CABO Comparison

Compare KALV & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$17.04

Market Cap

757.7M

Sector

Health Care

ML Signal

HOLD

Logo Cable One Inc.

CABO

Cable One Inc.

HOLD

Current Price

$98.58

Market Cap

641.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
CABO
Founded
N/A
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
757.7M
641.2M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
KALV
CABO
Price
$17.04
$98.58
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$30.00
$125.67
AVG Volume (30 Days)
761.7K
126.9K
Earning Date
05-09-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,000,000.00
$1,501,423,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.94
P/E Ratio
N/A
N/A
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$70.37
52 Week High
$19.00
$277.97

Technical Indicators

Market Signals
Indicator
KALV
CABO
Relative Strength Index (RSI) 56.35 45.73
Support Level $14.59 $96.67
Resistance Level $17.30 $116.36
Average True Range (ATR) 1.10 8.85
MACD -0.04 -1.51
Stochastic Oscillator 57.48 21.22

Price Performance

Historical Comparison
KALV
CABO

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About CABO Cable One Inc.

Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.

Share on Social Networks: